Tyers Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $678K | Sell |
5,120
-3,216
| -39% | -$426K | 0.02% | 400 |
|
|
2019
Q2 | $1.18M | Buy |
8,336
+1,840
| +28% | +$261K | 0.04% | 303 |
|
|
2019
Q1 | $944K | Buy |
6,496
+1,952
| +43% | +$284K | 0.03% | 324 |
|
|
2018
Q4 | $514K | Sell |
4,544
-1,088
| -19% | -$123K | 0.02% | 403 |
|
|
2018
Q3 | $758K | Buy |
5,632
+768
| +16% | +$103K | 0.03% | 358 |
|
|
2018
Q2 | $546K | Sell |
4,864
-2,528
| -34% | -$284K | 0.02% | 412 |
|
|
2018
Q1 | $789K | Sell |
7,392
-48
| -0.6% | -$5.12K | 0.03% | 308 |
|
|
2017
Q4 | $814K | Buy |
7,440
+4,272
| +135% | +$467K | 0.03% | 318 |
|
|
2017
Q3 | $342K | Buy |
3,168
+480
| +18% | +$51.8K | 0.01% | 495 |
|
|
2017
Q2 | $272K | Buy |
2,688
+320
| +14% | +$32.4K | 0.01% | 542 |
|
|
2017
Q1 | $213K | Sell |
2,368
-96
| -4% | -$8.64K | 0.01% | 522 |
|
|
2016
Q4 | $188K | Buy |
+2,464
| New | +$188K | 0.01% | 509 |
|